11.07 USD
▲+0.66+2.88%
盘后 10.80 +0.37%
2026-08-03
市值
$537.87M
市盈率
—
EPS
-3.55
股息率
—
52 周区间
2.22 – 14.53
成交量
411.20K
Beta
2.18
目标价
35.80
52W 低 2.2252W 高 14.53
价格走势
公司简介
Artiva Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers. Its lead product candidate includes AlloNK, an off-the-shelf NK cell therapy for patients with autoimmune diseases and cancers, such as rheumatoid arthritis, systemic lupus erythematosus, lupus nephritis, rheumatoid arthritis, pemphigus vulgaris, the anti-neutrophil cytoplasmic antibody -associated vasculitis subtypes granulomatosis with polyangiitis/mic...